NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
FORT MYERS, Fla., April 23, 2026 BUSINESS WIRE NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that its oncology testing portfolio is now available through Epic Aura , enabling seamless access to oncologists and health systems across the United States through the Epic electronic health record (EHR) workflow. Through this integration, physicians can order NeoGenomics' comprehensive suite of tests, spanning solid tumors and hematologic malignancies, and view results in the same system they use to manage patient care. This streamlined approach lowers barriers to entry for hospitals and health systems, enhances the scalability of NeoGenomics' testing capabilities, and could drive 20-30% increase in test adoption per site, supporting faster time to treatment for patients facing a cancer diagnosis. "Clinicians need timely access to the right diagnostics within the systems they already rely on," said To
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura IntegrationBusiness Wire
- NeoGenomics (NEO) Q4 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026Business Wire
- NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026Business Wire
- 3 of Wall Street's Favorite Stocks We Think Twice About [Yahoo! Finance]Yahoo! Finance
NEO
Earnings
- 2/17/26 - Beat
NEO
Sec Filings
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form ARS
- 4/6/26 - Form DEF
- NEO's page on the SEC website